MiMedx Group Company Profile (NASDAQ:MDXG)

About MiMedx Group (NASDAQ:MDXG)

MiMedx Group logoMiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. OrthoFlo is amniotic fluid-derived allograft for homologous use. Physio is a bone grafting material consists of bone tissue with no added carrier. CollaFix, its new brand, is its collagen fiber technology designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:MDXG
  • CUSIP: N/A
  • Web: www.mimedx.com
Capitalization:
  • Market Cap: $1.55 billion
  • Outstanding Shares: 110,871,000
Average Prices:
  • 50 Day Moving Avg: $14.99
  • 200 Day Moving Avg: $11.40
  • 52 Week Range: $6.94 - $16.20
P/E:
  • Trailing P/E Ratio: 106.21
  • Foreward P/E Ratio: 37.56
  • P/E Growth: 3.33
Sales & Book Value:
  • Annual Revenue: $264.26 million
  • Price / Sales: 6.15
  • Book Value: $1.22 per share
  • Price / Book: 12.01
Profitability:
  • EBIDTA: $29.49 million
  • Net Margins: 5.72%
  • Return on Equity: 12.25%
  • Return on Assets: 8.39%
Debt:
  • Current Ratio: 2.46%
  • Quick Ratio: 2.13%
Misc:
  • Average Volume: 1.43 million shs.
  • Beta: 1.04
  • Short Ratio: 16.18
 
Frequently Asked Questions for MiMedx Group (NASDAQ:MDXG)

What is MiMedx Group's stock symbol?

MiMedx Group trades on the NASDAQ under the ticker symbol "MDXG."

How will MiMedx Group's stock buyback program work?

MiMedx Group announced that its Board of Directors has approved a share buyback plan on Monday, April 10th 2017, which allows the company to repurchase $10,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 1.2% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's management believes its shares are undervalued.

How were MiMedx Group's earnings last quarter?

MiMedx Group, Inc (NASDAQ:MDXG) announced its quarterly earnings results on Friday, April, 28th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.00. The business had revenue of $72.60 million for the quarter, compared to analysts' expectations of $72.60 million. MiMedx Group had a net margin of 5.72% and a return on equity of 12.25%. The firm's revenue for the quarter was up 36.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.04 EPS. View MiMedx Group's Earnings History.

What guidance has MiMedx Group issued on next quarter's earnings?

MiMedx Group updated its FY17 earnings guidance on Friday, April, 28th. The company provided earnings per share guidance of $0.31-0.33 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.32. The company issued revenue guidance of $303.5-307.0 million, compared to the consensus revenue estimate of $304.53 million.

Where is MiMedx Group's stock going? Where will MiMedx Group's stock price be in 2017?

4 equities research analysts have issued 12 month price targets for MiMedx Group's stock. Their predictions range from $10.00 to $20.00. On average, they expect MiMedx Group's share price to reach $13.25 in the next year. View Analyst Ratings for MiMedx Group.

What are analysts saying about MiMedx Group stock?

Here are some recent quotes from research analysts about MiMedx Group stock:

  • 1. Needham & Company LLC analysts commented, "We expect the upcoming top line data from MDXG’s diabetic foot ulcer (DFU) and venous leg ulcer (VLU) multi-center randomized controlled trials (RCTs) to be positive catalysts. MDXG disclosed positive interim results from the VLU RCT during its 3/9/17 investor call. Assuming good final results, we expect the trials to drive growth by prompting more insurers to cover EpiFix and more physicians to use EpiFix." (6/26/2017)
  • 2. According to Zacks Investment Research, "MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Innovations in Regenerative Biomaterials is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant. " (2/21/2017)

Are investors shorting MiMedx Group?

MiMedx Group saw a decrease in short interest in June. As of June 30th, there was short interest totalling 20,263,818 shares, a decrease of 10.9% from the June 15th total of 22,752,219 shares. Based on an average daily trading volume, of 1,353,029 shares, the days-to-cover ratio is currently 15.0 days. Approximately 19.8% of the shares of the company are short sold.

Who are some of MiMedx Group's key competitors?

Who are MiMedx Group's key executives?

MiMedx Group's management team includes the folowing people:

  • Parker H. Petit Jr., Chairman of the Board, Chief Executive Officer
  • William Charles Taylor, President, Chief Operating Officer, Director
  • Michael J. Senken, Chief Financial Officer
  • Alexandra O. Haden, General Counsel, Secretary
  • Charles E. Koob, Director
  • Luis A. Aguilar, Independent Director
  • Joseph G. Bleser, Independent Director
  • J. Terry Dewberry, Independent Director
  • Charles R. Evans, Independent Director

Who owns MiMedx Group stock?

MiMedx Group's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.33%), Summit Creek Advisors LLC (0.33%), Westwood Management Corp IL (0.23%), Acadian Asset Management LLC (0.12%), Strs Ohio (0.06%) and Boston Advisors LLC (0.05%). Company insiders that own MiMedx Group stock include Alexandra O Haden, Charles Robert Evans, Parker H Petit and William Charles Taylor. View Institutional Ownership Trends for MiMedx Group.

Who sold MiMedx Group stock? Who is selling MiMedx Group stock?

MiMedx Group's stock was sold by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Boston Advisors LLC, Capstone Asset Management Co. and LS Investment Advisors LLC. View Insider Buying and Selling for MiMedx Group.

Who bought MiMedx Group stock? Who is buying MiMedx Group stock?

MiMedx Group's stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Strs Ohio, Russell Investments Group Ltd., State of Alaska Department of Revenue, Aperio Group LLC and Louisiana State Employees Retirement System. Company insiders that have bought MiMedx Group stock in the last two years include Alexandra O Haden, Charles Robert Evans and Parker H Petit. View Insider Buying and Selling for MiMedx Group.

How do I buy MiMedx Group stock?

Shares of MiMedx Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MiMedx Group's stock price today?

One share of MiMedx Group stock can currently be purchased for approximately $14.65.


MarketBeat Community Rating for MiMedx Group (NASDAQ MDXG)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  279
MarketBeat's community ratings are surveys of what our community members think about MiMedx Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for MiMedx Group (NASDAQ:MDXG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $13.25 (9.56% downside)

Analysts' Ratings History for MiMedx Group (NASDAQ:MDXG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/26/2017Needham & Company LLCReiterated RatingBuy$15.00 -> $20.00MediumView Rating Details
5/23/2017First AnalysisDowngradeEqual Weight -> Underweight$11.00HighView Rating Details
3/3/2017Piper Jaffray CompaniesInitiated CoverageOverweight -> Overweight$10.00N/AView Rating Details
11/7/2016AegisInitiated CoverageBuy$12.00N/AView Rating Details
6/29/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
4/19/2016Lake Street CapitalLower Price TargetBuy$15.00 -> $12.00N/AView Rating Details
1/13/2016Canaccord GenuityReiterated RatingBuy$12.00N/AView Rating Details
10/30/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$10.00N/AView Rating Details
(Data available from 7/26/2015 forward)

Earnings

Earnings History for MiMedx Group (NASDAQ:MDXG)
Earnings by Quarter for MiMedx Group (NASDAQ:MDXG)
Earnings History by Quarter for MiMedx Group (NASDAQ MDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/28/2017Q1 2017$0.07$0.07$72.60 million$72.60 millionViewN/AView Earnings Details
2/23/2017Q416$0.08$0.05$71.13 million$69.90 millionViewListenView Earnings Details
10/27/2016Q316$0.06$0.06$63.18 million$64.40 millionViewListenView Earnings Details
7/26/2016Q216$0.07$0.05$56.49 million$57.00 millionViewListenView Earnings Details
4/25/2016Q116$0.05$0.04$54.05 million$53.40 millionViewListenView Earnings Details
2/23/2016Q415$0.06$0.12$51.84 million$51.80 millionViewListenView Earnings Details
10/29/2015Q315$0.06$0.06$48.61 million$49.00 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$45.03 million$45.68 millionViewListenView Earnings Details
4/27/2015Q1$0.03$0.04$40.77 millionViewListenView Earnings Details
2/26/2015Q414$0.03$0.03$38.15 million$39.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02$0.03$33.50 million$33.50 millionViewListenView Earnings Details
4/25/2014Q114($0.02)($0.01)$19.09 million$19.60 millionViewListenView Earnings Details
2/26/2014Q4($0.01)($0.04)$18.31 million$18.00 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.01)($0.01)$12.94 million$13.52 millionViewListenView Earnings Details
5/1/2013Q1 2013($0.02)($0.02)$11.34 million$11.56 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MiMedx Group (NASDAQ:MDXG)
2017 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.04$0.06$0.05
Q2 20172$0.04$0.04$0.04
Q3 20171$0.07$0.07$0.07
Q4 20172$0.08$0.12$0.10
Q1 20181$0.06$0.06$0.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MiMedx Group (NASDAQ:MDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for MiMedx Group (NASDAQ:MDXG)
Insider Ownership Percentage: 12.40%
Institutional Ownership Percentage: 55.75%
Insider Trades by Quarter for MiMedx Group (NASDAQ:MDXG)
Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)
Insider Trades by Quarter for MiMedx Group (NASDAQ:MDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017William Charles TaylorInsiderSell80,000$14.52$1,161,600.00View SEC Filing  
5/25/2017William Charles TaylorInsiderSell26,571$13.74$365,085.54View SEC Filing  
4/27/2017William Charles TaylorInsiderSell26,000$11.40$296,400.00View SEC Filing  
9/6/2016William Charles TaylorInsiderSell20,400$7.55$154,020.00View SEC Filing  
8/1/2016William Charles TaylorInsiderSell29,112$7.55$219,795.60View SEC Filing  
6/16/2016William Charles TaylorCOOSell24,333$7.52$182,984.16View SEC Filing  
5/20/2016Parker H PetitCEOBuy20,000$6.99$139,800.00View SEC Filing  
5/17/2016Parker H PetitCEOBuy30,000$6.82$204,600.00View SEC Filing  
5/13/2016Parker H PetitCEOBuy40,000$6.75$270,000.00View SEC Filing  
5/12/2016Parker H PetitCEOBuy50,000$6.74$337,000.00View SEC Filing  
11/13/2015Charles Robert EvansDirectorBuy10,000$7.84$78,400.00View SEC Filing  
11/10/2015Parker H PetitCEOBuy131,925$7.58$999,991.50View SEC Filing  
10/30/2015Alexandra O. HadenGeneral CounselBuy4,150$7.92$32,868.00View SEC Filing  
5/28/2015Larry W PapasanDirectorSell5,958$10.09$60,116.22View SEC Filing  
5/18/2015William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
10/31/2014William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
7/1/2014William Charles TaylorCOOSell150,000$7.50$1,125,000.00View SEC Filing  
1/17/2014Parker PetitCEOSell150,000$8.28$1,242,000.00View SEC Filing  
8/28/2013William Charles TaylorCOOSell9,800$6.15$60,270.00View SEC Filing  
8/7/2013William Charles TaylorCOOSell183,765$6.21$1,141,180.65View SEC Filing  
5/16/2013Steve GorlinDirectorSell30,000$6.46$193,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for MiMedx Group (NASDAQ:MDXG)
Latest Headlines for MiMedx Group (NASDAQ:MDXG)
Source:
DateHeadline
americanbankingnews.com logoMiMedx Group, Inc (MDXG) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 17 at 12:33 PM
americanbankingnews.com logoMiMedx Group, Inc (NASDAQ:MDXG) Short Interest Down 10.9% in June
www.americanbankingnews.com - July 15 at 7:26 AM
thestreet.com logoMiMedx Spikes After Q2 Earnings Beat; Mylan Pops on New Breast Cancer Drug -Biotech Movers - TheStreet.com
www.thestreet.com - July 15 at 6:24 AM
streetinsider.com logoMiMedx Group (MDXG) Prelim. Q2 Revenue Beats - StreetInsider.com
www.streetinsider.com - July 15 at 6:24 AM
finance.yahoo.com logoMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : July 14, 2017
finance.yahoo.com - July 15 at 6:24 AM
finance.yahoo.com logoMiMedx Spikes After Q2 Earnings Beat; Mylan Pops on New Breast Cancer Drug -Biotech Movers
finance.yahoo.com - July 15 at 6:24 AM
streetinsider.com logoAfter-Hours Stock Movers 7/13: (CLIR) (BLFS) (AFMD) Higher; (ATEN) (CYBR) (FEYE) Lower (more...)
www.streetinsider.com - July 14 at 6:24 AM
bizjournals.com logoMiMedx Announces That Its Second Quarter Revenue Exceeds The Guidance Range
www.bizjournals.com - July 14 at 6:24 AM
finance.yahoo.com logo/C O R R E C T I O N -- MiMedx Group, Inc./
finance.yahoo.com - July 14 at 6:24 AM
finance.yahoo.com logoETFs with exposure to MiMedx Group, Inc. : July 11, 2017
finance.yahoo.com - July 12 at 3:24 AM
prnewswire.com logoMiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down - PR Newswire (press release)
www.prnewswire.com - July 6 at 2:25 AM
americanbankingnews.com logoBidaskClub Lowers MiMedx Group, Inc (MDXG) to Hold
www.americanbankingnews.com - July 5 at 7:28 PM
finance.yahoo.com logoMiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down
finance.yahoo.com - July 5 at 4:21 PM
finance.yahoo.com logoETFs with exposure to MiMedx Group, Inc. : June 30, 2017
finance.yahoo.com - July 1 at 1:03 AM
americanbankingnews.com logoMiMedx Group, Inc (MDXG) Earns Buy Rating from Needham & Company LLC
www.americanbankingnews.com - June 26 at 12:16 PM
streetinsider.com logoMiMedx Group (MDXG) PT Raised to $20 at Needham & Company; 'We Expect Wound RCTs to Drive Increased EpiFix ... - StreetInsider.com
www.streetinsider.com - June 26 at 9:10 AM
americanbankingnews.com logoMiMedx Group, Inc (MDXG) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - June 24 at 5:32 PM
prnewswire.com logoMedical Equipment Stock Performance Review -- MiMedx, Stryker, Zimmer Biomet, and ResMed
www.prnewswire.com - June 22 at 8:45 AM
americanbankingnews.com logoMiMedx Group, Inc (MDXG) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 20 at 12:46 PM
finance.yahoo.com logoETFs with exposure to MiMedx Group, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 5:31 PM
americanbankingnews.com logoWilliam Charles Taylor Sells 80,000 Shares of MiMedx Group, Inc (MDXG) Stock
www.americanbankingnews.com - June 16 at 10:16 PM
finance.yahoo.com logoMiMedx Group, Inc. :MDXG-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 7:26 PM
streetinsider.com logoMiMedx Group (MDXG): Scientific & Clinical Review Highlights ... - StreetInsider.com
www.streetinsider.com - June 16 at 7:39 AM
finance.yahoo.com logoScientific And Clinical Review Confirms Potential Of MiMedx dHACM Allografts For Regenerative Applications In Orthopedics
finance.yahoo.com - June 16 at 7:39 AM
streetinsider.com logoMiMedx Group (MDXG) Says Amniofix Data Presented at ASCRS
www.streetinsider.com - June 13 at 11:38 PM
streetinsider.com logoMiMedx Group (MDXG) Says Amniofix Data Presented at ASCRS - StreetInsider.com
www.streetinsider.com - June 13 at 6:37 PM
finance.yahoo.com logoMiMedx Amniofix® data showing colorectal anastomotic leak rate reduction presented at ASCRS Meeting
finance.yahoo.com - June 13 at 6:37 PM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Short Interest Up 6.0% in May
www.americanbankingnews.com - June 11 at 12:46 PM
seekingalpha.com logoMiMedx Group (MDXG) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - June 8 at 7:25 PM
americanbankingnews.com logoAnalyzing Varian Medical Systems (VAR) and MiMedx Group (MDXG)
www.americanbankingnews.com - June 6 at 2:06 PM
finance.yahoo.com logoMiMedx to Present at the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - June 1 at 9:28 AM
americanbankingnews.com logoWilliam Charles Taylor Sells 26,571 Shares of MiMedx Group Inc (MDXG) Stock
www.americanbankingnews.com - May 30 at 7:41 PM
americanbankingnews.com logoFirst Analysis Downgrades MiMedx Group Inc (MDXG) to Underweight
www.americanbankingnews.com - May 28 at 12:32 AM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Short Interest Down 18.1% in May
www.americanbankingnews.com - May 27 at 7:06 AM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 26 at 1:31 PM
finance.yahoo.com logoMiMedx To Attend The 14th Annual Craig-Hallum Institutional Investor Conference
finance.yahoo.com - May 19 at 11:01 AM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Short Interest Down 10.7% in April
www.americanbankingnews.com - May 12 at 7:08 AM
streetinsider.com logoMiMedx Group (MDXG) Announces EpiFix Coverage From Kaiser Permanente - StreetInsider.com
www.streetinsider.com - May 4 at 6:35 PM
streetinsider.com logoMiMedx Group (MDXG) Announces EpiFix Coverage From Kaiser Permanente
www.streetinsider.com - May 4 at 11:43 AM
finance.yahoo.com logoMiMedx EpiFix® Receives Coverage From Kaiser Permanente
finance.yahoo.com - May 4 at 11:43 AM
americanbankingnews.com logoMiMedx Group (MDXG) Earns Daily Coverage Optimism Rating of 0.51
www.americanbankingnews.com - May 2 at 10:00 PM
americanbankingnews.com logoFirst Analysis Comments on MiMedx Group Inc's Q1 2018 Earnings (MDXG)
www.americanbankingnews.com - May 2 at 2:50 PM
finance.yahoo.com logoMiMedx Group, Inc.: Leads amongst peers with strong fundamentals
finance.yahoo.com - May 1 at 5:29 PM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - May 1 at 4:42 PM
finance.yahoo.com logoMiMedx Receives Innovative Technology Supplier of the Year Award from Vizient, Inc.
finance.yahoo.com - May 1 at 12:42 PM
finance.yahoo.com logoEdited Transcript of MDXG earnings conference call or presentation 28-Apr-17 2:30pm GMT
finance.yahoo.com - May 1 at 12:42 PM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Expected to Announce Quarterly Sales of $70.64 Million
www.americanbankingnews.com - April 30 at 7:54 AM
americanbankingnews.com logoPositive News Coverage Very Likely to Affect MiMedx Group (MDXG) Stock Price
www.americanbankingnews.com - April 29 at 6:11 PM
americanbankingnews.com logoMiMedx Group Inc (MDXG) Issues Quarterly Earnings Results
www.americanbankingnews.com - April 29 at 1:14 AM
americanbankingnews.com logoWilliam Charles Taylor Sells 26,000 Shares of MiMedx Group Inc (MDXG) Stock
www.americanbankingnews.com - April 29 at 1:10 AM

Social

Chart

MiMedx Group (MDXG) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff